Sorbifer Durules (ferrous sulfate, Ascorbic Acid)
33253USD

Sorbifer Durules (ferrous sulfate, Ascorbic Acid)

SKU:1326
To favorites
Sorbifer Durules (ferrous sulfate, Ascorbic Acid) antianemic drug, iron deficiency anemia
Active substance:Iron sulfate, Ascorbic Acid
Pharmacological group:Iron preparations
Formulation:Tablets
Country of origin:Hungary
In stock
In stock
Ordered on demand
$32
11
Description
Features
Reviews

Instructions for Sorbifer Durules (ferrous sulfate, Ascorbic Acid)

The form of the issue, the composition and packaging of the Tablets, covered with a light yellow shell, round, double-convex, engraved on one side, on the kink - the core of gray, with a characteristic smell.

1 tablet
ascorbic acid (vit. C) 60 mg
iron sulfate 320 mg
equivalent to Fe2's 100 mg content

Auxiliary substances: magnesium stearat, povidon K-25, polyethylene powder, carbomer 934R.

The composition of the shell: hypromellosis, macrogol 6000, titanium dioxide, iron oxide yellow, paraffin solid. 30 pieces - vials of dark glass (1) - packs of cardboard. 50 pieces - vials of dark glass (1) - packs of cardboard.

Clinical and Pharmacological Group: Antianemic Drug

Pharmacological action Antianemetic drug.
Iron sulfate makes up for the lack of iron in the body. Ascorbic acid improves its absorption from the gastrointestinal tract. Prolonged release of bivalent iron ions from Sorbifer Durules tablets prevents undesirable increases in iron ions in the gastrointestinal tract and prevents their irritating effect on the mucous membrane.

Pharmacokinetics:

After taking the drug iron absorption occurs quite slowly because as the Sorbifer Durules pill passes through the LCT release of iron ions from the permeable matrix occurs within 6 hours. 

Indication

  • treatment of iron deficiency anemia (if insufficient input iron in the body with food, with the body's increased need for iron;
    chronic blood loss)
  • Prevention of iron deficiency anemia (including during pregnancy and lactation, in women of childbearing age, in children and adolescents during intensive growth, in elderly people).
  • chronic blood loss);
  • Prevention of iron deficiency anemia (including during pregnancy and lactation, in women of childbearing age, in children and adolescents during intensive growth, in elderly people).

Dosing mode:

For treatment of iron deficiency anemia adults and teenagers over 12 years are prescribed 1 pill 2 times/day in the morning and in the evening. When developing side effects, the dose should be reduced to 1 pill 1 time/ For the prevention of iron deficiency anemia, as well as for anemia in I and II trimesters of pregnancy are prescribed for 1 pill/day, in III trimester - 1 pill 2 times/ During lactation 1 pill 2 times/ The duration of treatment is determined individually under the control of iron content in plasma. In the case of clinical cases of iron deficiency the duration of treatment is 3-6 months. In normalization of the hemoglobin indicator the therapy should continue for about 2 months up to saturation of the iron depot in the body.

Side action:

by the digestive system: slight nausea, pain in epigastria, diarrhea, or constipation. Contraindications - constriction of the esophagus and/or other obstructive diseases of the LCD; -pathological conditions caused by elevated iron deposit in the body; -Children up to 12 years of age; -increased sensitivity to the drug Ascorbic Acid.

Application during pregnancy and breast feeding Sorbifer Durules may be used during pregnancy and during lactation on the basis of indications. Sorbifer Durulez's special instructions are effective only in case of iron deficiency and iron-deficiency anemia.
The prescription of the drug Sorbifer Durules for anemia not related to iron deficiency is unreasonable.
Before prescription of the drug Sorbifer Durules it is necessary to confirm the presence of iron deficiency with laboratory research data.

Overdose of Symptoms:

pale, cyanosis, drowsiness, abdominal pain, nausea, vomiting. Treatment: gastric washing, deferoxamine assignment (with iron concentration in serum above 5 ug/ml).

Symptomatic therapy is provided if necessary. Pharmaceutical interaction When using Sorbifer Durules with tetracyclines and D-penicillamine simultaneously, iron absorption is reduced due to the formation of chelates (this combination is not recommended). When simultaneously using Sorbifer Durules with anthacids containing aluminum, magnesium and calcium salts, iron absorption is reduced (this combination is not recommended). The condition and term of storage The drug Ascorbic Acidshould be kept at room temperature (not more than 25°C).
Shelf life - 3 year

Features
Active substance
Pharmacological group
Formulation
Country of origin
Expiration Date
No reviews yet — your comment may be first.
All reviews 0
general rating